Instylla

Instylla, Inc. is a privately held company based in Massachusetts that focuses on developing next-generation liquid embolic agents for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis. The company’s first product, Embrace HES, is designed for controlled, complete, and durable embolization in these clinical settings.